Evidence map›Paper›PMID 33108537›Full record

ArticleHuman genetics2021

Genetic analyses of a large cohort of infertile patients with globozoospermia, DPY19L2 still the main actor, GGN confirmed as a guest player.

Tristan Celse, Caroline Cazin, Flore Mietton, Guillaume Martinez, Delphine Martinez, Nicolas Thierry-Mieg, Amandine Septier, Catherine Guillemain, Julie Beurois, Antoine Clergeau and 33 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Human genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Deletion of theInternational journal of molecular sciences · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors at 17 institutions in 1 country.

Tristan CelseInstitute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.
Caroline CazinInstitute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.
Flore MiettonCHU Grenoble Alpes, UM GI-DPI, 38000, Grenoble, France.
Guillaume MartinezInstitute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.
Delphine MartinezCHU Grenoble Alpes, UM GI-DPI, 38000, Grenoble, France.
Nicolas Thierry-MiegUniversité Grenoble Alpes, CNRS, TIMC-IMAG, 38000, Grenoble, France.
Amandine SeptierUniversité Grenoble Alpes, CNRS, TIMC-IMAG, 38000, Grenoble, France.
Catherine GuillemainPôle Femmes-Parents-Enfants, Centre Clinico-Biologique AMP-CECOS, Plateforme Cancer et Fertilité ONCOPACA-Corse, Assistance-Publique des Hôpitaux de Marseille (AP-HM), Marseille, France.
Julie BeuroisInstitute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.
Antoine ClergeauDiabetes Care Unit, University Hospital of Caen, Caen, France.
Selima Fourati Ben MustaphaPolyclinique les Jasmins, Centre d'Aide Médicale à la Procréation, Centre Urbain Nord, 1003, Tunis, Tunisia.
Mahmoud KharoufPolyclinique les Jasmins, Centre d'Aide Médicale à la Procréation, Centre Urbain Nord, 1003, Tunis, Tunisia.
Abdelali ZoghmarReproduction Sciences and Surgery Clinique, Ibn Rochd, Constantine, Algeria.
Ahmed CharguiFaculté de Médecine, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Universitaire Paris Centre, Centre Hospitalier Universitaire (CHU) Cochin, Service d'Histologie-Embryologie-Biologie de la Reproduction, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Aline PapaxanthosDepartment of Obstetrics, Gynecology and Reproductive Medicine, Bordeaux University Hospital, Bordeaux, France.
Béatrice DorphinAMP74, CH Alpes Léman, Contamine-sur-Arve, France.
Bernard FoliguetToxicology and Molecular Biology, Institute Jean Lamour UMR 7198 du CNRS, Université de Lorraine, 54000, Nancy, France.
Chema TrikiCentre d'AMP, Clinique Hannibal, Les Berges du Lac, 1053, Tunis, Tunisia.
Christophe SiferService de Biologie de la Reproduction, d'Histo-Embryologie et Cytogénétique, Hôpital Jean-Verdier, Avenue du 14 Juillet, 93140, Bondy, France.
Dominique LautonDepartment of Endocrinology, Diabetes, Nutrition, Montpellier University Hospital, Montpellier, France.
Gérard TachdjianUMR 967, INSERM, Service d'Histologie Embryologie et Cytogénétique, Hôpitaux Universitaires Paris-Sud, AP-HP, Clamart, France.
Gilles SchulerGynécologie Obstétrique, Sallanches, France.
Hervé LejeuneReproductive Medicine Department, Hospices Civils de Lyon, Lyon, France.
Jacques PuechbertyDépartement de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de Montpellier, Université Montpelier, Montpellier, France.
Julien BessonnatCHU de Grenoble, UF de Biologie de la Procréation, 38000, Grenoble, France.
Laurent PasquierService de Génétique Clinique, CLAD Ouest, CHU Rennes, Rennes, France.
Lionel MeryService de Médecine de la Reproduction, CHU de Saint-Étienne, Hôpital Nord, 42055, Saint-Étienne Cedex 2, France.
Marine PoulainDepartment of Obstetrics and Gynecology, Hôpital Foch, Université de Paris Ouest (UVSQ), Suresnes, France.
Myriam ChaabouniPolyclinique les Jasmins, Centre d'Aide Médicale à la Procréation, Centre Urbain Nord, 1003, Tunis, Tunisia.
Nathalie SermondadeService de Biologie de la Reproduction-CECOS, Hôpital Tenon, AP-HP, 75020, Paris, France.
Rosalie CabryDepartment of Obstetrics, Gynaecology and Reproductive Medicine, Picardie University Jules Verne, Amiens University Medical Centre, Amiens, France.
Sebti BenbouhadjaReproduction Sciences and Surgery Clinique, Ibn Rochd, Constantine, Algeria.
Ségolène VeauCHU, Centre d'AMP-CECOS, University Rennes, 16 Boulevard de Bulgarie, 35000, Rennes, France.
Cynthia FrapsauceCHU Bretonneau, Médecine et Biologie de la Reproduction-CECOS, Tours, France.
Valérie MitchellEA 4308, Department of Reproductive Biology and Spermiology-CECOS Lille, University Medical Center, 59037, Lille, France.
Vincent AchardCECOS-Laboratoire de Biologie de la Reproduction, Pôle de Gynécologie Obstétrique et Reproduction (Gynépôle), Assistance Publique-Hôpitaux de Marseille (AP-HM) la Conception, 13005, Marseille, France.
Veronique SatreInstitute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.
Sylviane HennebicqInstitute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.
Raoudha ZouariPôle Femmes-Parents-Enfants, Centre Clinico-Biologique AMP-CECOS, Plateforme Cancer et Fertilité ONCOPACA-Corse, Assistance-Publique des Hôpitaux de Marseille (AP-HM), Marseille, France.
Christophe ArnoultInstitute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.
Zine-Eddine KherrafInstitute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.
Charles CouttonInstitute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France.
Pierre F RayInstitute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, 38000, Grenoble, France. pray@chu-grenoble.fr.ORCID http://orcid.org/0000-0003-1544-7449
Centre National de la Recherche Scientifique · FRCentre Hospitalier Universitaire de Grenoble · FRCentre Hospitalier Universitaire de Rennes · FRInserm · FRCentre Hospitalier Universitaire de Tours · FRHôpital Arnaud de Villeneuve · FRHôpital Jean-Verdier · FRHôpital Nord · FRHospices Civils de Lyon · FRSorbonne Université · FRUniversité de Bordeaux · FRUniversité de Caen Normandie · FRUniversité de Lille · FRUniversité de Montpellier · FRUniversité de Picardie Jules Verne · FRUniversité de Versailles Saint-Quentin-en-Yvelines · FRUniversité Paris Cité · FR

Funding

Agence Nationale de la Recherche FLAGEL_OME
6 · The paper itself

Abstract

Globozoospermia is a rare phenotype of primary male infertility inducing the production of round-headed spermatozoa without acrosome. Anomalies of DPY19L2 account for 50-70% of all cases and the entire deletion of the gene is by far the most frequent defect identified. Here, we present a large cohort of 69 patients with 20-100% of globozoospermia. Genetic analyses including multiplex ligation-dependent probe amplification, Sanger sequencing and whole-exome sequencing identified 25 subjects with a homozygous DPY19L2 deletion (36%) and 14 carrying other DPY19L2 defects (20%). Overall, 11 deleterious single-nucleotide variants were identified including eight novel and three already published mutations. Patients with a higher rate of round-headed spermatozoa were more often diagnosed and had a higher proportion of loss of function anomalies, highlighting a good genotype phenotype correlation. No gene defects were identified in patients carrying < 50% of globozoospermia while diagnosis efficiency rose to 77% for patients with > 50% of globozoospermia. In addition, results from whole-exome sequencing were scrutinized for 23 patients with a DPY19L2 negative diagnosis, searching for deleterious variants in the nine other genes described to be associated with globozoospermia in human (C2CD6, C7orf61, CCDC62, CCIN, DNAH17, GGN, PICK1, SPATA16, and ZPBP1). Only one homozygous novel truncating variant was identified in the GGN gene in one patient, confirming the association of GGN with globozoospermia. In view of these results, we propose a novel diagnostic strategy focusing on patients with at least 50% of globozoospermia and based on a classical qualitative PCR to detect DPY19L2 homozygous deletions. In the absence of the latter, we recommend to perform whole-exome sequencing to search for defects in DPY19L2 as well as in the other previously described candidate genes.

Indexed as

Cohort StudiesExome SequencingGene DeletionGenetic Association StudiesGenetic TestingHomozygoteHumansInfertility, MaleMaleMembrane ProteinsMutationPolymorphism, Single NucleotideSpermatozoaTeratozoospermiaTesticular HormonesDPY19L2 protein, humanMembrane ProteinsTesticular Hormones

Identifiers

PMID33108537
OpenAlexW3095882069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.